Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (<scp>dNLR</scp>), predicts overall survival in neuroendocrine tumours undergoing <scp>peptide receptor radionuclide therapy</scp>: A retrospective, cohort study of 557 patients
Journal of neuroendocrinology